NASDAQ : SERA
Sera Prognostics, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 2.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 80.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 78.50M |
| Enterprise Value | 1.25M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 38.48M |
| Shares Outstanding | 39.45M |
| Shares Change (YoY) | +26.34% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 5.01% |
| Owned by Institutions (%) | 44.36% |
| Float | 27.70M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,127.13 |
| Forward PS | 87.67 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 23.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.98 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5,328.29 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -45.03% |
| Return on Assets (ROA) | -23.48% |
| Return on Invested Capital (ROIC) | -30.88% |
| Return on Capital Employed (ROCE) | -59.79% |
| Weighted Average Cost of Capital (WACC) | 9.71% |
| Revenue Per Employee | $972 |
| Profits Per Employee | -$461,569 |
| Employee Count | 72 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -39.33% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 43.13 |
| Average Volume (20 Days) | 17,416 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 222,706 |
| Short Previous Month | 229,723 |
| Short % of Shares Out | 0.56% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 15.44 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 70,000 |
| Gross Profit | -105,000 |
| Operating Income | -37.30M |
| Pretax Income | -33.23M |
| Net Income | -33.23M |
| EBITDA | -36.54M |
| EBIT | -37.30M |
| Loss Per Share | -$0.66 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 46.45M |
| Total Debt | 3.00M |
| Net Cash | 77.26M |
| Net Cash Per Share | $1.96 |
| Equity (Book Value) | 59.38M |
| Book Value Per Share | 1.51 |
| Working Capital | 23.78M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -27.68M |
| Capital Expenditures | -466,000 |
| Depreciation & Amortization | 755,000 |
| Net Borrowing | -23,000 |
| Free Cash Flow | -28.15M |
| FCF Per Share | -$0.71 |
Margins
| Measure | Value |
|---|
| Gross Margin | -150.00% |
| Operating Margin | -53,282.86% |
| Pretax Margin | -47,475.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.34% |
| Shareholder Yield | -26.34% |
| Earnings Yield | -33.35% |
| FCF Yield | -35.68% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.50 |
| Price Target Difference | 176.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 338.94% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.16 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |